VLTriz-2 (Tirzepatide) is a research peptide under study for its potential role in incretin-related receptor signaling and metabolic pathway models. Preclinical research typically focuses on appetite signaling, glucose regulation markers, and energy-balance endpoints, often exploring the involvement of multiple receptors. It is intended solely for laboratory research and should not be used for human or animal consumption.
Fast pricing. No commitment. Instant response.